Quest Diagnostics and Waters will expand at-home HPV screening in 2027, offering extended genotyping via the Onclarity ...
Zacks Investment Research on MSN
Waters & Labcorp expand access to FDA-approved HPV screening tests
Waters WAT recently announced a partnership with Labcorp Holdings Inc. LH to expand access to the FDA-approved BD Onclarity ...
Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...
Bottom Line: The risk of detecting cervical precancer eight years after a negative human papillomavirus (HPV) screening was found to be similar to the risk after three years (the commonly recommended ...
Researchers have developed a simple, affordable human papillomavirus test that delivers results in less than an hour with no specialized laboratory required. The breakthrough could provide an option ...
High-risk HPV test is replacing cytology as the primary cervical cancer screening test in most countries, but many women over 65 years have never had an HPV test. Controversy remains on whether and ...
HUMAN papillomavirus (HPV) can lead to throat cancer in men and cervical cancer in women. Feeling healthy does not mean you ...
A prospective cohort study in Papua New Guinea found that restricting HPV DNA testing to eight high-risk types, with or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results